tiprankstipranks
Trending News
More News >

Genfit to receive EUR 26.5M Iqirvo milestone payment from Ipsen agreement

Genfit (GNFT) announced that Ipsen’s Iqirvo has been granted pricing and reimbursement in Italy for Primary Biliary Cholangitis. This step unlocks a new milestone payment of EUR 26.5M under its licensing and collaboration agreement with Ipsen (IPSEY), due upon pricing and reimbursement of Iqirvo in three European markets.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue